BIOSTEED GENE EXPRESSION TECH CO LTD has a total of 21 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Brazil, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are STEM CELL PHARMACEUTICALS INC, DERMAGEN AB and PHARMA PACIFIC PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 4 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 3 | |
#5 | Mexico | 2 | |
#6 | South Africa | 2 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Sun Li | 19 |
#2 | Zhou Weidong | 15 |
#3 | Yin Fenghong | 9 |
#4 | Wang Tiebing | 9 |
#5 | Xiao Qingjiang | 9 |
#6 | Zhuang Lu | 9 |
#7 | Liu Min | 7 |
#8 | Zhang Linzhong | 6 |
#9 | Shen Shiye | 6 |
#10 | Lu Qingsong | 6 |
Publication | Filing date | Title |
---|---|---|
CN101809038A | Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof | |
AU2007363326A1 | Y-type polyethylene glycol modified G-CSF and preparation method and use thereof | |
EP2196475A1 | INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION | |
AU2007358605A1 | Polyethylene glycol modified interferon alpha 2b and preparation method and applications thereof |